Cambridge Trust’s Sanofi SNY Stock Holding History

Cambridge Trust’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$12.1K	Hold	248	–	–	﹤0.01%	567
2023 Q4	$12.3K	Hold	248	–	–	﹤0.01%	559
2023 Q3	$13.3K	Hold	248	–	–	﹤0.01%	547
2023 Q2	$13.4K	Hold	248	–	–	﹤0.01%	569
2023 Q1	$13.5K	Hold	248	–	–	﹤0.01%	599
2022 Q4	$12K	Hold	248	–	–	﹤0.01%	616
2022 Q3	$9K	Sell	248 -360	-59%	-$16K	﹤0.01%	664
2022 Q2	$30K	Sell	608 -752	-55%	-$39.9K	﹤0.01%	560
2022 Q1	$70K	Sell	1,360 -251	-16%	-$13K	﹤0.01%	486
2021 Q4	$81K	Buy	+1,611	New	+$79.7K	﹤0.01%	454
2015 Q2	–	Sell	-7,091	Closed	-$350K	–	233
2015 Q1	$350K	Sell	7,091 -5,752	-45%	-$275K	0.03%	163
2014 Q4	$586K	Sell	12,843 -347,280	-96%	-$16.9M	0.05%	127
2014 Q3	$20.3M	Buy	360,123 +61,774	+21%	+$3.32M	1.8%	16
2014 Q2	$15.9M	Buy	298,349 +5,543	+2%	+$294K	1.37%	26
2014 Q1	$15.3M	Buy	292,806 +4,581	+2%	+$232K	1.41%	27
2013 Q4	$15.5M	Buy	288,225 +3,345	+1%	+$173K	1.44%	26
2013 Q3	$14.4M	Buy	284,880 +3,404	+1%	+$173K	1.44%	26
2013 Q2	$14.5M	Buy	+281,476	New	+$15M	1.5%	23

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Cambridge Trust's SNY Position: Q1 2024 in Review

Cambridge Trust held its Sanofi (SNY) position steady in Q1 2024 at 248 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #567.

Cambridge Trust first reported a position in SNY in Q2 2013 and has held it in 18 quarters since. The position peaked at $20.3M in Q3 2014. 713 funds tracked by Wall St. Rank hold SNY as of Q1 2024.

Cambridge Trust held 248 shares of Sanofi worth $12.1K as of Q1 2024.
Cambridge Trust left its Sanofi share count unchanged in Q1 2024.
Sanofi made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #567 holding.
Cambridge Trust first reported a position in Sanofi in Q2 2013 and has held it in 18 quarters since.
Cambridge Trust's Sanofi position peaked at $20.3M in Q3 2014.
713 funds tracked by Wall St. Rank held Sanofi as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.